Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry
Cancer Treatment and Research Communications · 2025
DOI: 10.1016/j.ctarc.2025.101016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Daneng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA. Electronic a…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Healthcare Disparities. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Hepatocellular carcinoma is the third-leading cause of cancer-related death worldwide. In the United States, California has the highest hepatocellular carcinoma incidence burden and a high level of racial/ethnic diversity. The impact of race/ethnicity on hepatocellular carcinoma treatment and survival in California has not been investigated. METHODS: We performed a retrospective analysis of patients diagnosed with hepatocellular carcinoma from 2000 to 2012 using the California Cancer Registry. Patients were categorized by race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, non-Hispanic Asian). Overall five-year survival was calculated using the Kaplan-Meier method. Cox proportional hazards univariable and multivariable analyses were performed to identify factors that influenced survival. RESULTS: We analyzed data from 12,288 patients (4545 non-Hispanic White; 942 non-Hispanic Black; 3299 Hispanic; 3502 non-Hispanic Asian). Non-Hispanic Black patients were least likely to receive systemic treatment, chemoembolization, or surgery. Overall five-year survival was highest for non-Hispanic Asian patients (22.9 %), followed by Hispanics (16.8 %), non-Hispanic Whites (16.5 %), and non-Hispanic Blacks (11.9 %) (log-rank P 70 years), race/ethnicity (non-Hispanic, non-Asian), low socioeconomic status, Deyo-Charlson comorbidity score ≥2, tumor size ≥5 cm, grade II/III/IV tumor differentiation, and AJCC stage of II, III, or IV at diagnosis. CONCLUSIONS: Multiple factors influence patients' hepatocellular carcinoma diagnosis, treatment, and survival. Future studies are needed to identify key factors that can impact treatment and survival among hepatocellular carcinoma patients of different racial/ethnic backgrounds. IMPACT: Despite California's diverse population, racial/ethnic backgrounds can still significantly impact treatment and survival among hepatocellular carcinoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA. Electronic address: danli@coh.org.
- Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
- Division of Biostatistics, Department of Computational and Quantitative Medicine, Beckman Research Institute, 1500 E Duarte Rd, Duarte, CA 91010, USA.
- Department of Surgery, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
- Department of Diagnostic Radiology, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
- Department of Medicine, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
Zitieren
APA
Li, D., Crook, C. J., Zhang, Y. H., Ruel, N., Ituarte, P. H. G., Kessler, J., Lee, A., Singh, D., & Singh, G. (2025). Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101016
Vancouver
Li D, Crook CJ, Zhang YH, Ruel N, Ituarte PHG, Kessler J, et al. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.101016
BibTeX
@article{Li2025,
author = {Li, Daneng and Crook, Christiana Joy and Zhang, Ya-Han and Ruel, Nora and Ituarte, Philip H G and Kessler, Jonathan and Lee, Aram and Singh, Dupinder and Singh, Gagandeep},
title = {Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry},
journal = {Cancer Treatment and Research Communications},
year = {2025},
doi = {10.1016/j.ctarc.2025.101016}
}
EUVIMED